ORCID as entered in ROS

Select Publications
2015, 'Fibrates: risk-benefits and role in treating dyslipidemias', in Dyslipidemias Pathophysiology, Evaluation and Management, Humana Press
,2011, 'Intensive glycemic control and renal outcome', in Diabetes and the Kidney, Karger Medical and Scientific Publishers
,2023, 'Antioxidants for adults with chronic kidney disease', Cochrane Database of Systematic Reviews, 2023, http://dx.doi.org/10.1002/14651858.CD008176.pub3
,2023, 'Duration and effectiveness of glucose-lowering regimens in the real world management of diabetes: Data from the Australian EXTEND45 Linked Cohort Study', Endocrine and Metabolic Science, 12, http://dx.doi.org/10.1016/j.endmts.2023.100135
,2023, 'Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study', European Heart Journal - Quality of Care and Clinical Outcomes, 9, pp. 621 - 631, http://dx.doi.org/10.1093/ehjqcco/qcac069
,2023, 'Short report: Factors contributing to young people's susceptibility to e-cigarettes in four countries', Drug and Alcohol Dependence, 250, http://dx.doi.org/10.1016/j.drugalcdep.2023.109944
,2023, 'Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials', Journal of the American Heart Association, 12, http://dx.doi.org/10.1161/JAHA.122.028516
,2023, 'Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada', Kidney Medicine, 5, http://dx.doi.org/10.1016/j.xkme.2023.100675
,2023, 'Characterization of Risk Prediction Models for Acute Kidney Injury: A Systematic Review and Meta-analysis', JAMA network open, 6, pp. e2313359, http://dx.doi.org/10.1001/jamanetworkopen.2023.13359
,2023, 'Clinical outcomes by atherosclerotic cardiovascular disease risk score and blood pressure level in high risk individuals with type 2 diabetes', Journal of Human Hypertension, 37, pp. 181 - 188, http://dx.doi.org/10.1038/s41371-022-00661-5
,2023, 'E-cigarettes: A continuing public health challenge in India despite comprehensive bans', Preventive Medicine Reports, 31, http://dx.doi.org/10.1016/j.pmedr.2022.102108
,2023, 'Comparing survival in patients with chronic kidney disease across three countries – Results from the study of heart and renal protection-extended review', Nephrology, 28, pp. 36 - 43, http://dx.doi.org/10.1111/nep.14127
,2023, 'Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', American Journal of Kidney Diseases, http://dx.doi.org/10.1053/j.ajkd.2023.07.023
,2023, 'WCN23-0200 PREVALENCE AND TREATMENT PATTERNS OF ANAEMIA IN INDIVIDUALS WITH CHRONIC KIDNEY DISEASE ACROSS ASIA', Kidney International Reports, 8, pp. S135 - S136, http://dx.doi.org/10.1016/j.ekir.2023.02.309
,2022, 'Young people's support for various forms of e-cigarette regulation in Australia and the UK', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103858
,2022, 'School staff perceptions of the nature and consequences of students’ use of e-cigarettes', Australian and New Zealand Journal of Public Health, 46, pp. 676 - 681, http://dx.doi.org/10.1111/1753-6405.13281
,2022, 'Canagliflozin, Visit-to-visit Blood Pressure Variability, And Risk Of Cardiovascular, Kidney, And Mortality Outcomes: Pooled Individual Participant Data From The CANVAS And CREDENCE Trials', HYPERTENSION, 79, http://dx.doi.org/10.1161/hyp.79.suppl_1.P201
,2022, 'Commentary on the 2020 update of the KDOQI clinical practice guideline for nutrition in chronic kidney disease', Nephrology, 27, pp. 537 - 540, http://dx.doi.org/10.1111/nep.14025
,2022, 'Sex differences in chronic kidney disease prevalence in Asia: A systematic review and meta-analysis', Clinical Kidney Journal, 15, pp. 1144 - 1151, http://dx.doi.org/10.1093/ckj/sfac030
,2022, 'Risk factors for incident kidney disease in older adults: an Australian prospective population-based study', Internal Medicine Journal, 52, pp. 808 - 817, http://dx.doi.org/10.1111/imj.15074
,2022, 'Prior Cardiovascular Treatments—A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction', Frontiers in Pharmacology, 13, pp. 834898, http://dx.doi.org/10.3389/fphar.2022.834898
,2022, 'The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 31, pp. 370 - 378, http://dx.doi.org/10.1002/pds.5395
,2022, 'A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP-HEPC trial)', Journal of Viral Hepatitis, 29, pp. 135 - 146, http://dx.doi.org/10.1111/jvh.13629
,2022, 'Prevalence of chronic kidney disease in Asia: A systematic review and analysis', BMJ Global Health, 7, http://dx.doi.org/10.1136/bmjgh-2021-007525
,2021, 'The risk of acute kidney injury with oral anticoagulants in elderly adults with atrial fibrillation', Clinical Journal of the American Society of Nephrology, 16, pp. 1470 - 1479, http://dx.doi.org/10.2215/CJN.05920421
,2021, 'The Potential Effectiveness of COVID-Related Smoking Cessation Messages in Three Countries', Nicotine and Tobacco Research, 23, pp. 1254 - 1258, http://dx.doi.org/10.1093/ntr/ntab023
,2021, 'Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi-database cohort study with meta-analysis', British Journal of Clinical Pharmacology, 87, pp. 2589 - 2601, http://dx.doi.org/10.1111/bcp.14669
,2021, 'Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial', Diabetes, Obesity and Metabolism, 23, pp. 1420 - 1425, http://dx.doi.org/10.1111/dom.14351
,2021, 'Quality of Life in Caregivers of Patients Randomized to Standard- Versus Extended-Hours Hemodialysis', Kidney International Reports, 6, pp. 1058 - 1065, http://dx.doi.org/10.1016/j.ekir.2021.01.020
,2021, 'The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes', Diabetes, Obesity and Metabolism, 23, pp. 763 - 773, http://dx.doi.org/10.1111/dom.14281
,2021, 'Treatment abandonment in children with cancer: Does a sex difference exist? A systematic review and meta-analysis of evidence from low- and middle-income countries', International Journal of Cancer, 148, pp. 895 - 904, http://dx.doi.org/10.1002/ijc.33279
,2021, 'Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor', Kidney International Reports, 6, pp. 284 - 295, http://dx.doi.org/10.1016/j.ekir.2020.10.039
,2021, 'Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomes', Diabetes, Obesity and Metabolism, 23, pp. 382 - 390, http://dx.doi.org/10.1111/dom.14226
,2021, 'Workforce capacity for the care of patients with kidney failure across world countries and regions', BMJ Global Health, 6, http://dx.doi.org/10.1136/bmjgh-2020-004014
,2021, 'The Impact of Clinical Presentation on Survival in Patients Requiring Hemodialysis Catheters for Acute and Unplanned Dialysis: A Prospective Observational Study', Canadian Journal of Kidney Health and Disease, 8, http://dx.doi.org/10.1177/20543581211009986
,2020, 'Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial', Journal of Diabetes, 12, pp. 929 - 941, http://dx.doi.org/10.1111/1753-0407.13083
,2020, 'Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data', Journal of Clinical and Translational Endocrinology, 22, http://dx.doi.org/10.1016/j.jcte.2020.100240
,2020, 'Preferences for tobacco cessation information and support during Covid-19', Journal of Addiction Medicine, 14, pp. E362 - E365, http://dx.doi.org/10.1097/ADM.0000000000000743
,2020, 'Therapy escalation following an elevated hba
2020, 'Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study', CMAJ open, 8, pp. E877 - E886, http://dx.doi.org/10.9778/cmajo.20200055
,2020, 'Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE-ON study', Diabetes, Obesity and Metabolism, 22, pp. 1818 - 1826, http://dx.doi.org/10.1111/dom.14103
,2020, 'Haemodialysis duration, frequency and intensity for end-stage kidney disease', Cochrane Database of Systematic Reviews, 2020, http://dx.doi.org/10.1002/14651858.CD010064.pub2
,2020, 'Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants', American Journal of Kidney Diseases, 76, pp. 311 - 320, http://dx.doi.org/10.1053/j.ajkd.2020.02.446
,2020, 'Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients', Cochrane Database of Systematic Reviews, 2020, http://dx.doi.org/10.1002/14651858.CD009966.pub3
,2020, 'Comparative efficacy and safety of bp-lowering pharmacotherapy in patients undergoing maintenance dialysis: A network meta-analysis of randomized, controlled trials', Clinical Journal of the American Society of Nephrology, 15, pp. 1129 - 1138, http://dx.doi.org/10.2215/CJN.12201019
,2020, 'Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study', Diabetologia, 63, pp. 1637 - 1647, http://dx.doi.org/10.1007/s00125-020-05162-z
,2020, 'Erratum: Estimating urine albumin-to-creatinine ratio from protein-to-creatinine ratio: Development of equations using same-DayMeasurements (Journal of the American Society of Nephrology (2020) 31 (591-601) DOI: 10.1681/ASN.2019060605)', Journal of the American Society of Nephrology, 31, pp. 1140, http://dx.doi.org/10.1681/ASN.2020030291
,2020, 'Incidence and associations of chronic kidney disease in community participants with diabetes: A 5-year prospective analysis of the EXTEND45 study', Diabetes Care, 43, pp. 982 - 990, http://dx.doi.org/10.2337/dc19-1803
,2020, 'Examining outcomes in chronic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study', JMIR Research Protocols, 9, http://dx.doi.org/10.2196/15646
,2020, 'Examining outcomes in chronic disease in the 45 and up study (the EXTEnD45 study): Protocol for an Australian linked cohort study', JMIR Research Protocols, 9, http://dx.doi.org/10.2196/15646
,